Faraday Future Invests Over $41 Million in Qualigen Therapeutics for Web3 and Crypto Push
Faraday Future leads a $41 million investment in Qualigen Therapeutics, gaining a controlling stake as the company rebrands to focus on Web3 and crypto initiatives.
Fact Check
Multiple sources corroborate that Faraday Future made a '$41 Million' investment in Qualigen Therapeutics. The evidence also consistently states that the purpose of the investment is for a new venture in the crypto and Web3 space. The statement is strongly supported, with the minor discrepancy of 'Over $41 Million' versus the '$41 Million' reported in the sources not altering the fundamental accuracy of the claim.
Summary
Faraday Future has completed a $41 million strategic investment in Qualigen Therapeutics, contributing $30 million for a 55% stake. Founder Jia Yueting added $4 million, securing a 7% stake, with a two-year lock-up. Qualigen, now rebranding to CXC10, will focus on expanding its crypto and Web3 efforts as part of FF's ecosystem strategy.
Terms & Concepts
- PIPE Financing: Private Investment in Public Equity; a method where institutional investors purchase stock directly from a public company at a set price.
- Equity Stake: The ownership interest held by an investor in a company, typically expressed as a percentage of total shares outstanding.